AsclepiX Therapeutics is Drug Discovery in United States that focus on developer business. Founded in 2011. They cover business area such as developer, biomimetic anti-angiogenic and anti-lymphangiogenic peptide, retinal disease, cancer, groundbreaking therapy, indication, ophthalmology, oncology, patient, doctor, ocular ailment.
2011
( 13 years old in 2024 )
Developer
-
301 West 29th Street
Suite 2004
Baltimore, MD 21211
United States
Private
developerbiomimetic anti-angiogenic and anti-lymphangiogenic peptideretinal diseasecancergroundbreaking therapyindicationophthalmologyoncologypatientdoctorocular ailment
* We use standard office opening hours in near AsclepiX Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AsclepiX Therapeutics is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), AsclepiX Therapeutics business is focusing on Developer.
AsclepiX Therapeutics headquarter office and corporate office address is located in 301 West 29th Street Suite 2004 Baltimore, MD 21211 United States.
AsclepiX Therapeutics was founded in United States.
In 2024, AsclepiX Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AsclepiX Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
